1 1 = 3. combined use of anti-her2 agents in the neoadjuvant setting
Published 7 months ago • 4 plays • Length 9:30Download video MP4
Download video MP3
Similar videos
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
22:59
asco 2013 - breast cancer (neo-adjuvant therapy in her2 )
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
24:56
her2 testing in breast cancer: asco-cap guideline update
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
-
34:31
chair's take: her2-targeted and other agents for gastric cancer
-
8:47
chemotherapy and targeted therapy for her2-negative metastatic breast cancer that is either endoc...
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
17:40
case 3: potential role of neoadjuvant therapy in a 61 yo woman with t2 n3 her2 /er-/pr- bc
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
8:21
stereotactic radiosurgery in combination with anti-her2 therapy for her2 breast cancer brain mets
-
13:34
systemic therapy for advanced her2-positive breast cancer guideline update
-
16:06
spotlight poster discussion: "her2 kinase inhibitors: neoadjuvant approaches and mechanisms of..."
-
16:19
case 1: potential role of neoadjuvant therapy for a 30 yo woman with t2 n1 bc
-
8:13
systemic therapy for patients with advanced her2 positive breast cancer guideline
-
0:56
dr. jhaveri discusses the utility of t-dm1 in the neoadjuvant setting
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
2:49
her2-e pcr with anti-her2-based neoadjuvant therapies